Jean-Marc GHIGO

Prof. Jean-Marc GHIGO

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2001 in Nature
Verified
Journal Article
Closed access
JGJean-Marc GHIGO
Jean-Marc GHIGO

15 December 2010 in Journal of Bacteriology
Verified
Journal Article
Closed access
LFLionel FerrièrEs
Lionel FerrièrEs
GHGaëlLe HémEry
GaëlLe HémEry
TNToan Nham
Toan Nham
AGAnne-Marie GuérOut
Anne-Marie GuérOut
DMDidier Mazel
Didier Mazel
JGJean-Marc GHIGO
Jean-Marc GHIGO
Random transposon mutagenesis is the strategy of choice for associating a phenotype with its unknown genetic determinants. It is generally performed by mobilization of a conditionally replicating vector delivering transposons to recipient cells using broad-host-range RP4 conjugative machinery carried by the donor strain. In the present study, we demonstrate that bacteriophage Mu, which was deliberately introduced during the original construction of the widely used donor strains SM10 λ pir and S17-1 λ pir , is silently transferred to Escherichia coli recipient cells at high frequency, both by hfr and by release of Mu particles by the donor strain. Our findings suggest that bacteriophage Mu could have contaminated many random-mutagenesis experiments performed on Mu-sensitive species with these popular donor strains, leading to potential misinterpretation of the transposon mutant phenotype and therefore perturbing analysis of mutant screens. To circumvent this problem, we precisely mapped Mu insertions in SM10 λ pir and S17-1 λ pir and constructed a new Mu-free donor strain, MFD pir , harboring stable hfr- deficient RP4 conjugative functions and sustaining replication of Π-dependent suicide vectors. This strain can therefore be used with most of the available transposon-delivering plasmids and should enable more efficient and easy-to-analyze mutant hunts in E. coli and other Mu-sensitive RP4 host bacteria.

25 February 2015 in FEMS Microbiology Reviews
Verified
Journal Article
Open access
PDF file
BABianca Audrain
Bianca Audrain
MFMohamed A. Farag
Mohamed A. Farag
CRChoong-Min Ryu
Choong-Min Ryu
JGJean-Marc GHIGO
Jean-Marc GHIGO
Bacterial interactions with neighboring microorganisms via production of small metabolites enable bacteria to respond and adapt to environmental changes. The study of intercellular interactions primarily focused on soluble metabolites, but bacteria also produce and release into their headspace a wide variety of volatile secondary metabolites, the ecological roles of which have generally been overlooked. However, bacterial volatile compounds are known to contribute to interkingdom interactions (plant, fungi and nematodes), and recent studies also identified their at-a-distance influence on bacterial behavior. The present review describes the biological roles of bacterial volatile compounds in inter- and intraspecies bacterial interactions, a new and yet unexplored research area, with potential clinical and industrial applications.

1 January 2008
Verified
Book Chapter
Closed access
PDF file
CBChristophe Beloin
Christophe Beloin
ARA. Roux
A. Roux
JGJean-Marc GHIGO
Jean-Marc GHIGO

1 September 2012 in FEMS Microbiology Reviews
Verified
Journal Article
Open access
PDF file
OROlaya Rendueles
Olaya Rendueles
JGJean-Marc GHIGO
Jean-Marc GHIGO
This review describes how nonbiocidal competitive interactions can profoundly impact on microbial behavior in biofilm environments and discusses the potential b

26 June 2012 in Environmental Microbiology
Verified
Journal Article
Open access
PDF file
OROlaya Rendueles
Olaya Rendueles
JKJeffrey B. Kaplan
Jeffrey B. Kaplan
JGJean-Marc GHIGO
Jean-Marc GHIGO
Summary: Bacterial extracellular polysaccharides have been shown to mediate many of the cell‐to‐cell and cell‐to‐surface interactions that are required for the formation, cohesion and stabilization of bacterial biofilms. However, recent studies have identified several bacterial polysaccharides that inhibit biofilm formation by a wide spectrum of bacteria and fungi both in vitro and in vivo . This review discusses the composition, modes of action and potential biological roles of antibiofilm polysaccharides recently identified in bacteria and eukarya. Some of these molecules may have technological applications as antibiofilm agents in industry and medicine.